These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31492291)

  • 61. Preclinical study of Doxorubicine-loaded liposomal drug delivery for the treatment of head and neck cancer: Optimization by Box-Behnken statistical design.
    Yang B
    Acta Biochim Pol; 2020 Jun; 67(2):149-155. PubMed ID: 32506868
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The construction of cell-penetrating peptide R8 and pH sensitive cleavable polyethylene glycols co-modified liposomes].
    Zhang L; Wang Y; Gao HL; He Q
    Yao Xue Xue Bao; 2015 Jun; 50(6):760-6. PubMed ID: 26521450
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency.
    Zhang T; Zhou S; Hu L; Peng B; Liu Y; Luo X; Liu X; Song Y; Deng Y
    Drug Deliv Transl Res; 2018 Jun; 8(3):602-616. PubMed ID: 29536348
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chitosan coated vancomycin hydrochloride liposomes: Characterizations and evaluation.
    Yang Z; Liu J; Gao J; Chen S; Huang G
    Int J Pharm; 2015 Nov; 495(1):508-515. PubMed ID: 26325316
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X; Li J; Yan M
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Cell penetrating peptide TAT and brain tumor targeting peptide T7 dual modified liposome preparation and in vitro targeting evaluation].
    Yuan DF; Zong TL; Gao HL; He Q
    Yao Xue Xue Bao; 2015 Jan; 50(1):104-10. PubMed ID: 25924484
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Formulation and
    Narendra ; Mehata AK; Viswanadh MK; Sonkar R; Pawde DM; Priya V; Singh M; Koch B; S Muthu M
    Ther Deliv; 2020 Sep; 11(9):557-571. PubMed ID: 32867624
    [No Abstract]   [Full Text] [Related]  

  • 68. Transferrin-conjugated nanodiamond as an intracellular transporter of chemotherapeutic drug and targeting therapy for cancer cells.
    Wang D; Li Y; Tian Z; Cao R; Yang B
    Ther Deliv; 2014 May; 5(5):511-24. PubMed ID: 24998271
    [TBL] [Abstract][Full Text] [Related]  

  • 69.
    Saavedra-Alonso S; Zapata-Benavides P; Chavez-Escamilla AK; Manilla-Muñoz E; Zamora-Avila DE; Franco-Molina MA; Rodriguez-Padilla C
    Exp Ther Med; 2016 Dec; 12(6):3778-3784. PubMed ID: 28105110
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
    Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
    Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
    Yuan M; Qiu Y; Zhang L; Gao H; He Q
    Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer.
    Paszko E; Vaz GM; Ehrhardt C; Senge MO
    Eur J Pharm Sci; 2013 Jan; 48(1-2):202-10. PubMed ID: 23159666
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.
    Pattni BS; Nagelli SG; Aryasomayajula B; Deshpande PP; Kulkarni A; Hartner WC; Thakur G; Degterev A; Torchilin VP
    Pharm Res; 2016 Oct; 33(10):2540-51. PubMed ID: 27351426
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid.
    Sriraman SK; Salzano G; Sarisozen C; Torchilin V
    Eur J Pharm Biopharm; 2016 Aug; 105():40-9. PubMed ID: 27264717
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of infliximab encapsulated in liposomes.
    Zhang R; Qian J; Li X; Yuan Y
    Br J Ophthalmol; 2017 Dec; 101(12):1731-1738. PubMed ID: 28986343
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Behaviour of cell penetrating peptide TAT-modified liposomes loaded with salvianolic acid B on the migration, proliferation, and survival of human skin fibroblasts.
    Shi J; Guo S; Wu Y; Chen G; Lai J; Xu X
    J Liposome Res; 2020 Mar; 30(1):93-106. PubMed ID: 31012367
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fattigation-platform nanoparticles using apo-transferrin stearic acid as a core for receptor-oriented cancer targeting.
    Amin HH; Meghani NM; Park C; Nguyen VH; Tran TT; Tran PH; Lee BJ
    Colloids Surf B Biointerfaces; 2017 Nov; 159():571-579. PubMed ID: 28854413
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
    Nag M; Gajbhiye V; Kesharwani P; Jain NK
    Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
    Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.
    Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J
    J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.